Diffusion Pharma executes 1:15 reverse split

|About: Diffusion Pharmaceutic... (DFFN)|By:, SA News Editor

Aimed at regaining compliance with Nasdaq's minimum bid price listing requirement, Diffusion Pharmaceuticals (DFFN) has executed a 1:15 reverse split of its common stock. Post-split trading began today.

Subscribe for full text news in your inbox